Pain Therapeutics

Pain Therapeutics, Inc. is a biopharmaceutical company dedicated to the development of new drugs. The company's primary candidate drug is called extended-release oxycodone capsules. Oxycodone is a powerful painkiller, and its unique formulation helps reduce the potential risks of unintended use. Oxycodone and three other non-abusable pain medications were developed under collaboration and license agreements (Pfizer Agreements) with King Pharmaceuticals, Inc., a subsidiary of Pfizer, Inc. The company was incorporated in Delaware in May 1998.